CLDX
Price
$21.35
Change
+$1.82 (+9.32%)
Updated
Jun 6 closing price
Capitalization
1.3B
59 days until earnings call
FENC
Price
$8.43
Change
+$0.53 (+6.71%)
Updated
Jun 6 closing price
Capitalization
228.14M
59 days until earnings call
Interact to see
Advertisement

CLDX vs FENC

Header iconCLDX vs FENC Comparison
Open Charts CLDX vs FENCBanner chart's image
Celldex Therapeutics
Price$21.35
Change+$1.82 (+9.32%)
Volume$852.59K
Capitalization1.3B
Fennec Pharmaceuticals
Price$8.43
Change+$0.53 (+6.71%)
Volume$120.96K
Capitalization228.14M
CLDX vs FENC Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. FENC commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and FENC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CLDX: $18.66 vs. FENC: $8.12)
Brand notoriety: CLDX and FENC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 127% vs. FENC: 75%
Market capitalization -- CLDX: $1.3B vs. FENC: $228.14M
CLDX [@Biotechnology] is valued at $1.3B. FENC’s [@Biotechnology] market capitalization is $228.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileFENC’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • FENC’s FA Score: 0 green, 5 red.
According to our system of comparison, FENC is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 3 TA indicator(s) are bullish while FENC’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 3 bullish, 6 bearish.
  • FENC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FENC is a better buy in the short-term than CLDX.

Price Growth

CLDX (@Biotechnology) experienced а -6.47% price change this week, while FENC (@Biotechnology) price change was -2.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CLDX is expected to report earnings on Aug 07, 2025.

FENC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.3B) has a higher market cap than FENC($228M). FENC YTD gains are higher at: 28.481 vs. CLDX (-26.158). FENC has higher annual earnings (EBITDA): 3.02M vs. CLDX (-191.9M). CLDX has more cash in the bank: 725M vs. FENC (40.3M). CLDX has less debt than FENC: CLDX (3.81M) vs FENC (32.1M). FENC has higher revenues than CLDX: FENC (49.3M) vs CLDX (7.02M).
CLDXFENCCLDX / FENC
Capitalization1.3B228M568%
EBITDA-191.9M3.02M-6,356%
Gain YTD-26.15828.481-92%
P/E RatioN/A60.43-
Revenue7.02M49.3M14%
Total Cash725M40.3M1,799%
Total Debt3.81M32.1M12%
FUNDAMENTALS RATINGS
CLDX vs FENC: Fundamental Ratings
CLDX
FENC
OUTLOOK RATING
1..100
326
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
6775
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6337
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (55) in the Biotechnology industry is somewhat better than the same rating for FENC (90). This means that CLDX’s stock grew somewhat faster than FENC’s over the last 12 months.

CLDX's Profit vs Risk Rating (67) in the Biotechnology industry is in the same range as FENC (75). This means that CLDX’s stock grew similarly to FENC’s over the last 12 months.

CLDX's SMR Rating (96) in the Biotechnology industry is in the same range as FENC (100). This means that CLDX’s stock grew similarly to FENC’s over the last 12 months.

FENC's Price Growth Rating (37) in the Biotechnology industry is in the same range as CLDX (63). This means that FENC’s stock grew similarly to CLDX’s over the last 12 months.

FENC's P/E Growth Rating (98) in the Biotechnology industry is in the same range as CLDX (100). This means that FENC’s stock grew similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXFENC
RSI
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 12 days ago
78%
Momentum
ODDS (%)
Bearish Trend 12 days ago
81%
N/A
MACD
ODDS (%)
Bearish Trend 12 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 12 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
81%
Advances
ODDS (%)
Bullish Trend 21 days ago
82%
Bullish Trend 19 days ago
75%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend about 1 month ago
79%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
69%
Aroon
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-5.66%
DNLI - CLDX
53%
Loosely correlated
-1.29%
BEAM - CLDX
53%
Loosely correlated
-0.88%
KYMR - CLDX
52%
Loosely correlated
+2.35%
RVMD - CLDX
49%
Loosely correlated
+2.04%
NTLA - CLDX
49%
Loosely correlated
+3.59%
More

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with ONPPF. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then ONPPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
-0.12%
ONPPF - FENC
48%
Loosely correlated
N/A
DNLI - FENC
45%
Loosely correlated
-1.29%
CLDX - FENC
44%
Loosely correlated
-5.66%
EYPT - FENC
43%
Loosely correlated
+18.12%
IDYA - FENC
43%
Loosely correlated
+0.72%
More